The median OS of SMAD4/TP53 mutated metastatic colorectal cancer patients was 24.2 months, compared to 42.2 months for the rest of the population (p = 0.0017) (Figure 2B). This evidence concerns the gene SMAD4 and metastatic colorectal cancer.